Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Kool

Showing results (251-260 of 318) with videos related to

Pageof 32
Sort By:
Nature|January 28, 2016
Active medulloblastoma enhancers reveal subgroup-specific cellular originsCharles Y Lin, Serap Erkek, Yiai Tong, et al.
Cancer Cell|November 5, 2013
Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomasSebastian Bender, Yujie Tang, Anders M Lindroth, et al.
Acta Neuropathologica|July 23, 2017
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcomePooja Panwalkar, Jonathan Clark, Vijay Ramaswamy, et al.
Neuro-Oncology|August 3, 2023
Mapping pediatric brain tumors to their origins in the developing cerebellumKonstantin Okonechnikov, Piyush Joshi, Mari Sepp, et al.
Developmental Cell|March 20, 2018
Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH MedulloblastomaDaniel J Merk, Jasmin Ohli, Natalie D Merk, et al.
Cell|May 28, 2013
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongationGabriel Leprivier, Marc Remke, Barak Rotblat, et al.
The Lancet. Oncology|May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trialGiles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.
Cancer Cell|September 12, 2018
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic ProfilingAntoine Forget, Loredana Martignetti, Stéphanie Puget, et al.
Neuro-Oncology|December 29, 2019
Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumorsMichael C Frühwald, Martin Hasselblatt, Karolina Nemes, et al.
Nature Communications|July 13, 2022
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumorsJasmin Bartl, Marco Zanini, Flavia Bernardi, et al.
Pageof 32

Showing results (251-260 of 318) with videos related to

Sort By:
Pageof 32
Nature|January 28, 2016
Active medulloblastoma enhancers reveal subgroup-specific cellular originsCharles Y Lin, Serap Erkek, Yiai Tong, et al.
Cancer Cell|November 5, 2013
Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomasSebastian Bender, Yujie Tang, Anders M Lindroth, et al.
Acta Neuropathologica|July 23, 2017
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcomePooja Panwalkar, Jonathan Clark, Vijay Ramaswamy, et al.
Neuro-Oncology|August 3, 2023
Mapping pediatric brain tumors to their origins in the developing cerebellumKonstantin Okonechnikov, Piyush Joshi, Mari Sepp, et al.
Developmental Cell|March 20, 2018
Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH MedulloblastomaDaniel J Merk, Jasmin Ohli, Natalie D Merk, et al.
Cell|May 28, 2013
The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongationGabriel Leprivier, Marc Remke, Barak Rotblat, et al.
The Lancet. Oncology|May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trialGiles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.
Cancer Cell|September 12, 2018
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic ProfilingAntoine Forget, Loredana Martignetti, Stéphanie Puget, et al.
Neuro-Oncology|December 29, 2019
Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumorsMichael C Frühwald, Martin Hasselblatt, Karolina Nemes, et al.
Nature Communications|July 13, 2022
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumorsJasmin Bartl, Marco Zanini, Flavia Bernardi, et al.
Pageof 32